Kidney function and cognitive health in older adults: The cardiovascular health study

American Journal of Epidemiology

Volumn 180, Issue 1, 2014, Pages 68-75

  Darsie, Brendan ^a   Shlipak, Michael G ^b,c   Sarnak, Mark J ^d   Katz, Ronit ^e   Fitzpatrick, Annette L ^e   Odden, Michelle C ^a  

^a OREGON STATE UNIVERSITY   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

stroke

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C;

ADULT; AGING POPULATION; CARDIOVASCULAR DISEASE; COGNITION; EXCRETION; HEALTH SURVEY; PUBLIC HEALTH; RISK FACTOR;

AGED; ARTICLE; BODY MASS; COGNITION; COGNITIVE DEFECT; DETERIORATION; DIASTOLIC BLOOD PRESSURE; DIGIT SYMBOL SUBSTITUTION TEST; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

UNITED STATES;

AGING; CHRONIC KIDNEY DISEASE; COGNITIVE FUNCTION; CONGESTIVE HEART FAILURE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; STROKE; SUCCESSFUL AGING;

AGED; CARDIOVASCULAR DISEASES; COGNITION; COGNITION DISORDERS; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH STATUS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 84903973905     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu102     Document Type: Article

References (36)

1. Sarnak MJ, Katz R, Fried LF, et al. Cystatin C and aging success. Arch Intern Med. 2008;168(2):147-153.
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
3. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145(4): 237-246.
4. Shlipak MG, Stehman-Breen C, Fried LF, et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis. 2004;43(5):861-867.
5. Fried LF, Lee JS, Shlipak M, et al. Chronic kidney disease and functional limitation in older people: Health, Aging and Body Composition Study. J Am Geriatr Soc. 2006;54(5): 750-756.
6. Elias MF, Elias PK, Seliger SL, et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009;24(8):2446-2452.
7. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2008;52(2):227-234.
8. Buchman AS, Tanne D, Boyle PA, et al. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009;73(12):920-927.
9. Davey A, Elias MF, Robbins MA, et al. Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant. 2013;28(7):1810-1819.
10. Helmer C, Stengel B, Metzger M, et al. Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study. Neurology. 2011;77(23):2043-2051.
11. Khatri M, Nickolas T, Moon YP, et al. CKD associates with cognitive decline. J Am Soc Nephrol. 2009;20(11): 2427-2432.
12. Seliger SL, Siscovick DS, Stehman-Breen CO, et al. Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol. 2004;15(7):1904-1911.
13. Wang F, Zhang L, Liu L, et al. Level of kidney function correlates with cognitive decline. Am J Nephrol. 2010;32(2): 117-121.
14. Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the Health, Aging, and Body Composition Study. J Am Soc Nephrol. 2005; 16(7):2127-2133.
15. Jassal SK, Kritz-Silverstein D, Barrett-Connor E. A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo Study. Am J Epidemiol. 2010;171(3): 277-286.
16. Elias MF, Dore GA, Davey A. Kidney disease and cognitive function. Contrib Nephrol. 2013;179:42-57.
17. Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial. 2008;21(1):29-37.
18. Ghidoni R, Benussi L, Glionna M, et al. Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment. J Alzheimers Dis. 2010;22(3): 985-991.
19. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221-226.
20. Lamb EJ, O'Riordan SE, Delaney MP. Kidney function in older people: pathology, assessment and management. Clin Chim Acta. 2003;334(1-2):25-40.
21. Yaffe K, Lindquist K, Shlipak MG, et al. Cystatin C as a marker of cognitive function in elders: findings from the Health ABC Study. Ann Neurol. 2008;63(6):798-802.
22. Sundelöf J, Arnlöv J, Ingelsson E, et al. Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology. 2008; 71(14):1072-1079.
23. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3): 263-276.
24. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48(8):314-318.
25. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York, NY: Psychological Corporation; 1955.
26. Arnold AM, Newman AB, Dermond N, et al. Using telephone and informant assessments to estimate missing Modified Mini-Mental State Exam scores and rates of cognitive decline. The Cardiovascular Health Study. Neuroepidemiology. 2009; 33(1):55-65.
27. Kuller LH, Shemanski L, Manolio T, et al. Relationship between Apo E, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 1998;29(2):388-398.
28. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999;59(1): 1-8.
29. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29.
30. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5(4):278-285.
31. Weuve J, Tchetgen Tchetgen EJ, Glymour MM, et al. Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology. 2012;23(1): 119-128.
32. Sinisi SE, van der Laan MJ. Deletion/substitution/addition algorithm in learning with applications in genomics. Stat Appl Genet Mol Biol. 2004;3(1):Article18.
33. Etgen T, Sander D, Chonchol M, et al. Chronic kidney disease is associated with incident cognitive impairment in the elderly: the INVADE Study. Nephrol Dial Transplant. 2009;24(10): 3144-3150.
34. Slinin Y, Paudel ML, Ishani A, et al. Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc. 2008;56(11):2082-2088.
35. Seliger SL, Longstreth WT Jr, Katz R, et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol. 2005;16(12): 3721-3727.
36. Weiner DE, Bartolomei K, Scott T, et al. Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis. 2009;53(3):438-447.